JAG-ONE Physical Therapy

JAG-ONE is a direct-operating healthcare-services company, not a family office, fund manager, or investment vehicle. The firm runs over 160 outpatient physical and occupational therapy clinics and deploys capital solely into clinical operations, site expansion, and service-line development. No publicly available records indicate LP commitments, co-investment programs, or fund structures.

As of 2026, JAG-ONE publicly states it operates more than 160 locations across New Jersey, New York, and Pennsylvania. Earlier disclosures placed the count above 100, indicating sustained clinic growth. The firm's own materials list specific sites from the Bronx and Brooklyn through New Jersey counties down to the Philadelphia suburbs, reflecting broad tristate coverage.

No. JAG-ONE's disclosed activity is limited to clinical service delivery — outpatient rehabilitation, athletic training, and employer-partnered injury prevention. The firm has not disclosed any minority investments, venture allocations, or fund commitments, distinguishing it sharply from family offices that allocate to external managers or direct deals.

The firm treats general orthopedic, sports and soft-tissue injuries, post-operative cases, workers' compensation claimants, Medicare patients, and pediatric populations. It also offers specialty lines such as vestibular rehabilitation and teletherapy. This payer mix — commercial, government, and employer-direct — shapes a revenue profile typical of a scaled outpatient rehabilitation operator.

JAG-ONE competes with national consolidators like ATI Physical Therapy and Select Medical's Concentra, as well as regional independent groups. Its competitive moat rests on clinic density in the tristate area, team-sports provider relationships that drive referral volume, and an integrated service model spanning occupational therapy, industrial rehab, and athletic training. Market share is achieved through site count rather than capital-allocator strategies.